SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
54.60    -1.40 (-2.50%)
Bid:
52.60
Ask:
56.60
Spread: 4.00 (7.605%)
Market Cap: £45.60m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Trading Statement

13 Jul 2007 07:00

Flomerics Group PLC13 July 2007 Flomerics Group PLC ("Flomerics" or "the Company") Pre-Close Trading Update Flomerics Group PLC, the global supplier of specialist simulation software forelectronics and fluid flow simulation, is today providing a trading update inadvance of its interim results for the six months ended 30 June 2007. Although the first six months of the year have been challenging, the Companycontinues to make progress in integrating the Nika business, building awarenessof the Nika products in new markets and expanding its pipeline of opportunities.Through its expanded portfolio of products and additional selling capacity, theCompany is well positioned to develop its business robustly. However, asindicated in the AGM statement, building this pipeline and translating theopportunities into sales is taking longer than had been expected. This isparticularly so in the USA, where the Company has found the market weaker thanin the previous year. Flomerics continues to see a very positive reaction to the Nika product range inthose markets in which it has been introduced. It continues to build on crossselling opportunities of Nika solutions to existing Flomerics customers in theelectronics sector and is seeing benefits as a result of having broadened itsmarket beyond electronics. The directors expect the Company to report a loss in the first half of thisyear, because the costs of the investment in additional sales staff early in theyear will not be offset by increases in revenue, which are flowing through moreslowly than expected. The Company's results for the year will therefore dependeven more than usual on performance in the second half. Moreover, forecasts forthe Nika business are more difficult than for the traditional Flomericsbusiness, because it involves more sales of new products and a shorter salescycle. The Company's forecasting systems, which are well established for itstraditional business, are therefore currently showing a range of possibleoutcomes for the year. The current market expectation is at the upper end of therange and, as indicated in the AGM statement, actions are being taken to improveperformance and increase the likelihood of achieving this expectation. We willgive clearer guidance on the outlook for the year in the interim report. The Company expects to announce its interim results for the six months ended 30June 2007 in mid September 2007. Enquiries: Flomerics Group PLC:Gary Carter, Chief Executive 020 8847 3000Chris Ogle, Finance Director 020 8847 3000 Conduit PR:Christian Taylor-Wilkinson 020 7429 6666 Oriel Securities Limited (Nominated Adviser):Andrew Edwards 020 7710 7600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th May 20242:54 pmRNSNotice of AGM
9th May 20247:00 amRNSAnnual Financial Report
1st May 20247:00 amRNSHolding(s) in Company
18th Apr 20244:10 pmRNSDirector/PDMR Shareholding
27th Mar 20242:28 pmRNSClarification note regarding Dividend - REPLACE
26th Mar 20247:16 amRNS2023 Annual Unaudited Results
25th Mar 202411:44 amRNSNotice of Results
1st Feb 202410:38 amRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSTrading update
19th Dec 20237:00 amRNSHolding(s) in Company
25th Oct 202311:42 amRNSHolding(s) in Company
31st Aug 20234:25 pmRNSBoard Update
31st Aug 20237:00 amRNSPDMRs - Director Dealings
30th Aug 20237:00 amRNS2023 Half-year report
31st Jul 20237:00 amRNSTrading update & Notice of Half-year results
13th Jun 20231:42 pmRNSResult of AGM
5th Jun 20237:00 amRNSAwards under Long-Term Incentive Plan
5th Jun 20237:00 amRNSBoard update
19th May 20237:00 amRNSAvailability of Documents & Notice of 2023 AGM
15th May 20237:00 amRNSDirector Dealing
26th Apr 20237:01 amRNSAudited Annual Financial Report FY2022
12th Apr 20237:00 amRNSDirectorate Change
12th Apr 20237:00 amRNSUnaudited Preliminary Results-year ended 31.12.22
24th Mar 20237:00 amRNSNotice of Results - revised date
9th Mar 20238:00 amRNSAnnual Results and Presentation via IMC Platform
26th Jan 20237:00 amRNSTrading Update and Notice of Results
11th Jan 20237:00 amRNSBoard changes: NED Appointment & NED Retirement
21st Dec 20224:39 pmRNSHolding(s) in Company
31st Aug 20227:00 amRNSHalf-year Report - six months ended 30 June 2022
8th Aug 20226:27 pmRNSHolding(s) in Company
4th Aug 20227:30 amRNS2022 Half-Year Results - Investor Presentation
1st Aug 20227:00 amRNSGroup Trading Update & Notice of HY1 2022 results
21st Jul 20221:03 pmRNSHolding(s) in Company
1st Jun 20222:23 pmRNSResult of AGM and Total Voting Rights
18th May 20227:00 amRNSDirector/PDMR Shareholding
5th May 20222:20 pmRNS2021 Annual Report & Notice of 2022 AGM
3rd May 20227:00 amRNSGrant of Options under Long-Term Incentive Plan
30th Mar 20221:21 pmRNSDirector/PDMR Shareholding
29th Mar 20227:00 amRNSFY2021 Results & publication of the Annual Report
25th Mar 20225:36 pmRNSHolding(s) in Company
7th Mar 20229:00 amRNSNotice of Results and Investor Presentation
21st Feb 20225:49 pmRNSHolding(s) in Company
26th Jan 20227:01 amRNSTrading Statement
26th Jan 20227:00 amRNSAppointment of Nominated Adviser and Sole Broker
20th Jan 20224:41 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
20th Dec 202112:58 pmRNSHolding(s) in Company
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
15th Nov 20217:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.